Journal of Biological Chemistry · 2007 · 80 citations · 27 references
MedicineBiochemistryPharmacologyMolecular BiophysicsMolecular PharmacologyStructural BiologyDrug-receptor InteractionsG Protein-coupled Receptor SignalingLigand BindingProtein DynamicsProtein StructureReceptor-ligand InteractionsConformational Changes In ReceptorsConformational Flexibility Of ReceptorsFluorescence MonitoringG-protein-coupled ReceptorsProtein Conformational ChangesProtein Structural ChangesReceptor Conformational DynamicsReceptor Flexibility
Models describing the structural changes mediating Cys loop receptor activation generally give little attention to the possibility that different agonists may promote activation via distinct M2 pore-lining domain structural rearrangements. We investigated this question by comparing the effects of different ligands on the conformation of the external portion of the homomeric α1 glycine receptor M2 domain. Conformational flexibility was assessed by tethering a rhodamine fluorophore to cysteines introduced at the 19′ or 22′ positions and monitoring fluorescence and current changes during channel activation. During glycine activation, fluorescence of the label attached to R19′C increased by ∼20%, and the emission peak shifted to lower wavelengths, consistent with a more hydrophobic fluorophore environment. In contrast, ivermectin activated the receptors without producing a fluorescence change. Although taurine and β-alanine were weak partial agonists at the α1R19′C glycine receptor, they induced large fluorescence changes. Propofol, which drastically enhanced these currents, did not induce a glycine-like blue shift in the spectral emission peak. The inhibitors strychnine and picrotoxin elicited fluorescence and current changes as expected for a competitive antagonist and an open channel blocker, respectively. Glycine and taurine (or β-alanine) also produced an increase and a decrease, respectively, in the fluorescence of a label attached to the nearby L22′C residue. Thus, results from two separate labeled residues support the conclusion that the glycine receptor M2 domain responds with distinct conformational changes to activation by different agonists. Models describing the structural changes mediating Cys loop receptor activation generally give little attention to the possibility that different agonists may promote activation via distinct M2 pore-lining domain structural rearrangements. We investigated this question by comparing the effects of different ligands on the conformation of the external portion of the homomeric α1 glycine receptor M2 domain. Conformational flexibility was assessed by tethering a rhodamine fluorophore to cysteines introduced at the 19′ or 22′ positions and monitoring fluorescence and current changes during channel activation. During glycine activation, fluorescence of the label attached to R19′C increased by ∼20%, and the emission peak shifted to lower wavelengths, consistent with a more hydrophobic fluorophore environment. In contrast, ivermectin activated the receptors without producing a fluorescence change. Although taurine and β-alanine were weak partial agonists at the α1R19′C glycine receptor, they induced large fluorescence changes. Propofol, which drastically enhanced these currents, did not induce a glycine-like blue shift in the spectral emission peak. The inhibitors strychnine and picrotoxin elicited fluorescence and current changes as expected for a competitive antagonist and an open channel blocker, respectively. Glycine and taurine (or β-alanine) also produced an increase and a decrease, respectively, in the fluorescence of a label attached to the nearby L22′C residue. Thus, results from two separate labeled residues support the conclusion that the glycine receptor M2 domain responds with distinct conformational changes to activation by different agonists. Glycine receptor (GlyR) 4The abbreviations used are: GlyR, glycine receptor; MTSR, methanethiosulfonate-rhodamine; M1-M4, transmembrane segments 1-4; nAChR, nicotinic acetylcholine receptor; TMRM, tetramethylrhodamine-maleimide; VCF, voltage-clamp fluorometry; WT, wild type; TRITC, tetramethylrhodamine isothiocyanate. chloride channels mediate inhibitory neurotransmission in the central nervous system (1Lynch J.W. Physiol. Rev. 2004; 84: 1051-1095Crossref PubMed Scopus (625) Google Scholar). They comprise an assembly of five subunits that are each composed of a large N-terminal extracellular ligand-binding domain and four transmembrane α-helices (M1-M4). Cryo-electron microscopy images of the homologous Torpedo electropax nicotinic acetylcholine receptor (nAChR) transmembrane region reveals that the pore-lining M2 domains are kinked radially inward to form a central constriction at the membrane midpoint (2Miyazawa A. Fujiyoshi Y. Unwin N. Nature. 2003; 424: 949-955Crossref Scopus (1088) Google Scholar). There is currently a great deal of interest in understanding how M2 domains move to open the channel. Although the original model proposed a drastic rotation of M2 domains about their long axes (3Unwin N. Nature. 1995; 373: 37-43Crossref PubMed Scopus (914) Google Scholar), more recent evidence suggests that there is little if any rotation during receptor activation (4Wilson G.G. Karlin A. Neuron. 1998; 20: 1269-1281Abstract Full Text Full Text PDF PubMed Scopus (171) Google Scholar, 5Cymes G.D. Ni Y. Grosman C. Nature. 2005; 438: 975-980Crossref PubMed Scopus (141) Google Scholar, 6Paas Y. Gibor G. Grailhe R. Savatier-Duclert N. Dufresne V. Sunesen M. de Carvalho L.P. Changeux J.P. Attali B. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 15877-15882Crossref PubMed Scopus (65) Google Scholar). The precise nature of the structural change remains a matter for debate. The central pore kink is likely to introduce a degree of structural discontinuity because the hydrogen bonds responsible for maintaining α-helix rigidity are most likely broken. The kink may therefore act as a swivel enabling the outer half of M2 to move asynchronously with the inner half, where the gate is most likely positioned. Indeed, several lines of evidence suggest gating is mediated by a backbone rearrangement at this midpoint (7Akabas M.H. Kaufmann C. Archdeacon P. Karlin A. Neuron. 1994; 13: 919-927Abstract Full Text PDF PubMed Scopus (358) Google Scholar, 8England P.M. Zhang Y. Dougherty D.A. Lester H.A. Cell. 1999; 96: 89-98Abstract Full Text Full Text PDF PubMed Scopus (111) Google Scholar, 9Law R.J. Forrest L.R. Ranatunga K.M. La Rocca P. Tieleman D.P. Sansom M.S. Proteins. 2000; 39: 47-55Crossref PubMed Scopus (57) Google Scholar, 10Cymes G.D. Grosman C. Auerbach A. Biochemistry. 2002; 41: 5548-5555Crossref PubMed Scopus (79) Google Scholar). In addition, a rate equilibrium free energy state analysis shows that the M2-M3 domain is positioned midway along the agonist-induced “conformational wave” that extends from the ligand binding domain to the gate (11Grosman C. Zhou M. Auerbach A. Nature. 2000; 403: 773-776Crossref PubMed Scopus (290) Google Scholar). These considerations imply that the outer part of M2 should be an informative place to investigate the structural basis of receptor activation, as the movements in this region should not reflect either those occurring at the ligand binding site or the activation gate. Thus, in this study we probe conformational changes at the 19′ and 22′ residues, near the external end of M2. Current models of Cys loop receptor activation consider only structural changes associated with transitions from the resting closed state to the agonist-induced open state (5Cymes G.D. Ni Y. Grosman C. Nature. 2005; 438: 975-980Crossref PubMed Scopus (141) Google Scholar, 6Paas Y. Gibor G. Grailhe R. Savatier-Duclert N. Dufresne V. Sunesen M. de Carvalho L.P. Changeux J.P. Attali B. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 15877-15882Crossref PubMed Scopus (65) Google Scholar, 12Unwin N. J. Mol. Biol. 2005; 346: 967-989Crossref PubMed Scopus (1426) Google Scholar, 13Lee W.Y. Sine S.M. Nature. 2005; 438: 243-247Crossref PubMed Scopus (245) Google Scholar). Relatively little attention has been given to the possibility that different agonists and pharmacological modulators may promote different structural conformations in the pore region. However, it has been suggested on the basis of substituted cysteine accessibility studies that the pore blocker, picrotoxin, can change the conformation of the outer GlyR pore region suggesting in turn that it may interact allosterically with agonist-induced conformational changes (14Hawthorne R. Lynch J.W. J. Biol. Chem. 2005; 280: 35836-35843Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar). Our aim is to investigate the conformational changes induced by agonists, antagonists, and allosteric modulators by covalently labeling different residues near the extracellular M2 boundary with the sulfhydryl-reactive fluorophores, methanethiosulfonate-rhodamine (MTSR) and tetramethylrhodamine-maleimide (TMRM), and simultaneously measuring current changes and fluorescence changes (15Dahan D.S. Dibas M.I. Petersson E.J. Auyeung V.C. Chanda B. Bezanilla F. Dougherty D.A. Lester H.A. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 10195-10200Crossref PubMed Scopus (77) Google Scholar, 16Gandhi C.S. Isacoff E.Y. Trends Neurosci. 2005; 28: 472-479Abstract Full Text Full Text PDF PubMed Scopus (26) Google Scholar). This approach has been employed so far in only a few studies on Cys loop receptors (15Dahan D.S. Dibas M.I. Petersson E.J. Auyeung V.C. Chanda B. Bezanilla F. Dougherty D.A. Lester H.A. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 10195-10200Crossref PubMed Scopus (77) Google Scholar, 17Chang Y. Weiss D.S. Nat. Neurosci. 2002; 5: 1163-1168Crossref PubMed Scopus (87) Google Scholar, 18Muroi Y. Czajkowski C. Jackson M.B. Biochemistry. 2006; 45: 7013-7022Crossref PubMed Scopus (43) Google Scholar). A particular advantage of the GlyR is that it displays little or no desensitization thereby facilitating the quantitation of ligand-induced fluorescence spectral shifts. Chemicals—Glycine, CaCl2, MgCl2, KCl, NaCl, and glycerol were all purchased from Ajax Finechem (Seven Hills, New South Wales, Australia). HEPES was purchased from Amresco (Solon, OH). Sulforhodamine and were in and at and ivermectin were in and at was purchased from and at was in and at and β-alanine were also in and at GlyR α1 was the used in this study the which the extracellular J.W. J. J. Neurosci. PubMed Google Scholar). to the and L22′C was with the La of the was of the region. The was used to for were to and at and were and were from and in NaCl, KCl, MgCl2, The were in in for at and at were with of the the of for the of the the of and binding of the the were for at The NaCl, KCl, MgCl2, CaCl2, of receptors to were at for The were NaCl, KCl, MgCl2, CaCl2, and on were the labeling in for or in for The were and in for to labeling were on an was with a a and a system attached to the of the a and an emission were a A as a and was to the via a The of the is in D.S. Dibas M.I. Petersson E.J. Auyeung V.C. Chanda B. Bezanilla F. Dougherty D.A. Lester H.A. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 10195-10200Crossref PubMed Scopus (77) Google system by a was used for of the for were with and by to an were at a of in all and were a Current and fluorescence were at via a and The fluorescence was at with an for analysis and The was for where for changes in fluorescence an increase in The with a was used to or and for ligand-induced activation and results are as of the of five or more spectral analysis a to an the system on the of the The was a was used in with a no emission was to the the was the and lines of a the of the region of interest to be was with the of the from the region of interest was the and the was on the The of the the the the of the The for this of and was was used to of the α1R19′C shows of from with or α1R19′C The glycine are in In this and all the lines of the to the shows the and by the from to also shows the Lynch J.W. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar), the α1R19′C results in a glycine The was not different in α1R19′C to receptors The of labeling on was also in the in labeling produced no change in the of activated by glycine in However, glycine were in α1R19′C labeling with a current increase of lower in this was by a shift in the α1R19′C GlyR glycine the the glycine of the GlyR was not by the labeling and shows a model of M2 on of which shows the of the labeled rhodamine A. Lester and M. in and the to be part of the channel of results for current and fluorescence in a in at of with α1R19′C in an increase in resting fluorescence with that in or with not that glycine produced changes in fluorescence in that were in with the activated chloride current with changes in fluorescence at glycine In contrast, no was with or the and glycine were and suggesting a conformational changes at the 19′ and at the channel gate during activation. analysis of the fluorescence from α1R19′C that the fluorescence increase was by an blue shift in the emission peak during receptor activation and The of this shift was with glycine producing half of the shift produced by a glycine and The blue shift in the emission peak is of an increase in in the fluorophore most likely a of the fluorophore to a more hydrophobic in the open state (15Dahan D.S. Dibas M.I. Petersson E.J. Auyeung V.C. Chanda B. Bezanilla F. Dougherty D.A. Lester H.A. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 10195-10200Crossref PubMed Scopus (77) Google Scholar). did not or spectral of on R19′C to an as binding site and the GlyR in an Lynch J.W. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus (171) Google Scholar). the conclusion that it the GlyR via a different from glycine Lynch J.W. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus (171) Google Scholar), we to the and produced by ivermectin with that produced by In α1R19′C ivermectin that were the of those produced by glycine this large no increase in the fluorescence was Indeed, the fluorescence change in glycine currents, the was only Lynch J.W. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus (171) Google Scholar), the by ivermectin were only to with strychnine current by were in these results that ivermectin by a different from and β-alanine are agonists of with taurine a lower β-alanine J. Physiol. 2003; Scopus Google Scholar). are by a of R19′C Lynch J.W. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar, S. Lynch J.W. Neuron. 1995; Full Text PDF PubMed Scopus Google Scholar, J.W. S. J. PubMed Scopus Google Scholar). These suggest that taurine and β-alanine to the α1R19′C GlyR without the receptor and thereby they act as competitive of glycine this is their binding should not to investigate these ligands produced a change receptor binding if this was to that produced by of taurine did not a were taurine produced large changes in with a near that by a glycine and by taurine were by strychnine not results were with A of β-alanine only a current that produced by glycine in the it a large that was that produced by a glycine and by β-alanine were by strychnine not The current was to be with to the However, to taurine from the a of and of of β-alanine a and with no in their and The was with a of and an of the was with an of and an of for with also shows the and for glycine activation. The fluorescence and current for taurine and β-alanine were to those produced by glycine in the that the and produced by glycine activation was not during receptor activation by taurine or we that these produced different conformational changes at the 19′ residue. We investigated this by measuring the spectral changes produced by in taurine binding produced no spectral the spectral shift produced by β-alanine was that produced by glycine these results suggest that the binding of these weak partial agonists results in different conformational changes from those produced by of in the M2 the R19′C on receptor we assessed cysteine in the extracellular M2 region with on receptor a of to different agonists. A study Lynch J.W. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google that cysteine at the and 22′ positions receptor to a degree the R19′C Thus, we on these two the GlyR a glycine the was The no evidence of labeling by either or with or in the or of glycine produced no in to glycine not and fluorophore labeling produced no change in GlyR We that is either not labeled by these or that it no change in during receptor activation. The GlyR with those of and α1R19′C taurine and β-alanine as partial agonists as at receptors were labeled with MTSR, no change in be at glycine However, labeling by TMRM, a at glycine labeling also produced a increase in the glycine of and The of these quantitation or spectral analysis of the In to the of of of taurine or β-alanine a in and induced a current of and a of induced a current of and a of We the of the fluorescence change on the of the current or was of a glycine of a not different from those by taurine However, this of glycine produced no with A was for where induced by glycine were not different from those by β-alanine and the fluorescence changes were different in and with these results that glycine a different conformational change at L22′C to those produced by taurine and of GlyR on R19′C to the effects on the and of a competitive an allosteric picrotoxin, and a channel blocker, C. The of each of these at the GlyR has been Lynch J.W. 13: PubMed Scopus Google Scholar). strychnine did not or at a of However, with strychnine simultaneously and in the of and to strychnine were of the strychnine and of and the were by and of and Thus, strychnine induce conformational changes that are with a fluorophore attached to it can conformational changes. This is expected for a competitive the basis of a substituted cysteine accessibility it was proposed that picrotoxin can induce a conformational change in the M2-M3 loop that is not produced by glycine (14Hawthorne R. Lynch J.W. J. Biol. Chem. 2005; 280: 35836-35843Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar). We that picrotoxin may a different and was produced by of picrotoxin did not any changes in or at a of Although of picrotoxin with glycine the the analysis of an of and an of However, in the a of picrotoxin This is expected for a open state that the pore without the open state Although it no evidence to support the conclusion for picrotoxin a distinct conformational change in the M2-M3 loop (14Hawthorne R. Lynch J.W. J. Biol. Chem. 2005; 280: 35836-35843Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar), we the possibility that a conformational change may without a change in at We investigated the effects of the GlyR pore C. with strychnine and picrotoxin, of did not or with increased from an of and an of and an of and an of analysis that the of on the emission was to that produced by glycine with is the near for which we no the results that pore by a conformational change in M2-M3 to that produced by of of the of the GlyR is an that by binding to the and binding site and J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar, M.H. B. Trends Sci. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). of and currents, is by to in α1 S.M. B. J. Neurosci. 2004; PubMed Scopus (33) Google Scholar). is hydrophobic and binding site in to the MTSR, it may fluorescence by the of the the However, there was no change in the fluorescence α1R19′C were with for with and labeling in the of did not change or the resting fluorescence not a with α1R19′C the to current and fluorescence changes in to glycine increased the not the and the glycine for and and of results for and current and fluorescence from in a The drastically increased the and their were and The effects of on and for taurine and β-alanine are in and respectively, with of to the in with the and were shifted to lower The for taurine was increased by the for β-alanine was The for taurine and β-alanine were also increased by that β-alanine and taurine agonists, we their may to more those produced by no on the spectral of the induced by either β-alanine or taurine and for the of R19′C and L22′C from the site N. J. Mol. Biol. 2005; 346: 967-989Crossref PubMed Scopus (1426) Google and their midway along the conformational that extends from the binding site to the activation gate binding (11Grosman C. Zhou M. Auerbach A. Nature. 2000; 403: 773-776Crossref PubMed Scopus (290) Google Scholar), we that fluorescence from R19′C and L22′C are not likely to reflect ligand They are more likely to from a rotation or of the M2 during the conformational change that to channel During this conformational the fluorophore at the 19′ may move to a more hydrophobic environment. attached to L22′C a more hydrophobic activated by it a more activated by taurine or However, we the possibility that a or from the may to the fluorescence changes. Our not to the structural models of Cys loop receptor activation, they to M2 domain conformational changes produced by different Conformational most is that ivermectin the pore without producing a in the Although it has been suggested that ivermectin and glycine the GlyR pore via different Lynch J.W. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus (171) Google Scholar), the a for this The Cys loop receptor site is to be it is that ivermectin either to a transmembrane or an of where it or how it the receptor, it is that ivermectin the pore with no change in the conformation at the of M2. This the possibility that ivermectin conformational changes at the part of the M2 domain via an with the and β-alanine are agonists that are by Lynch J.W. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar, S. Lynch J.W. Neuron. 1995; Full Text PDF PubMed Scopus Google Scholar, J.W. S. J. PubMed Scopus Google Scholar). Although their at GlyR was ligands large that were not by blue in the spectral emission peak and This drastically from that produced by which was by a and and a blue shift in the emission spectral peak. Thus, the conformational change at produced by these ligands is distinct from that produced by This is not because it was from their that taurine and β-alanine different conformational changes to However, which drastically increased the with which and β-alanine were to no on the spectral of the and This is more as it shows that taurine and β-alanine no spectral change they the This a for taurine and β-alanine the GlyR pore via a different conformational change to However, a in this is that the R19′C may and to the that the results may not to the this we the conformational changes by a attached to the nearby L22′C residue. we that glycine produced a different to that elicited by taurine and β-alanine and This shows that the conformational changes not only to the α1R19′C also to a nearby with that more the these results to that different agonists the GlyR by producing different conformational changes to the external region of the M2 domain. Thus, the of M2 to a conformational that is not to movements of the channel gate. of the channel gate not to the of M2. has long been a competitive antagonist of the GlyR (1Lynch J.W. Physiol. Rev. 2004; 84: 1051-1095Crossref PubMed Scopus (625) Google Scholar). Our that strychnine inhibitory for and is consistent with this glycine from strychnine glycine from binding and from change. is to in the GlyR pore and to via an allosteric Lynch J.W. 13: PubMed Scopus Google Scholar). We on the basis of a substituted accessibility study that it changes the M2-M3 loop conformation in a that be by glycine (14Hawthorne R. Lynch J.W. J. Biol. Chem. 2005; 280: 35836-35843Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar). picrotoxin be expected to in a that be by glycine However, we that produced by picrotoxin glycine that produced by glycine This is expected for a pore that current without the open state receptor However, we the possibility that picrotoxin changes the conformation of the M2-M3 loop in a that not a change. lines of evidence suggest that in the GlyR pore 2002; PubMed Scopus Google Scholar, B. 2005; PubMed Scopus (33) Google Scholar, R. Lynch J.W. J. 2006; PubMed Scopus Google Scholar), there is no evidence to that they a conformational change to the covalently The results of that is by an increase in and a blue shift in the emission at those This is to with a model that only binding We that the changes are mediated by binding to a lower site distinct from the pore site at the In support of a study a site near the M2-M3 loop R. Lynch J.W. J. 2006; PubMed Scopus Google Scholar). is that the large of may the pore to in the activated However, the the and is not by this with and Weiss Y. Weiss D.S. Nat. Neurosci. 2002; 5: 1163-1168Crossref PubMed Scopus (87) Google employed to investigate at positions in and the A receptor ligand binding They that two is agonists produced a of at the labeled these changes also produced distinct in the of most picrotoxin produced a large at of the labeled evidence that by binding in the pore it conformational change Y. Weiss D.S. Nat. Neurosci. 2002; 5: 1163-1168Crossref PubMed Scopus (87) Google Scholar). A more recent study on and A receptors that the at two binding domain residues Y. Czajkowski C. Jackson M.B. Biochemistry. 2006; 45: 7013-7022Crossref PubMed Scopus (43) Google Scholar). The results from these two studies evidence for and conformational changes in the ligand binding domain. However, they no about these movements different movements at the (15Dahan D.S. Dibas M.I. Petersson E.J. Auyeung V.C. Chanda B. Bezanilla F. Dougherty D.A. Lester H.A. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 10195-10200Crossref PubMed Scopus (77) Google investigated and and changes at via a rhodamine label attached to the 19′ They that a conformational change at the The was also by the receptor desensitization with the these results that the M2 conformation a of the of the the of the labeled and the desensitization of the that the GlyR agonists, and different changes at labeled 19′ and 22′ The strychnine and picrotoxin, produced and changes as expected for a competitive antagonist and a channel blocker, respectively. the the channel blocker, produced an increase in that may a and a results suggest that the GlyR M2 domain responds with distinct conformational changes to the binding of different agonists. We for
27
Structure and gating mechanism of the acetylcholine receptor pore
Atsuo Miyazawa, Yoshinori Fujiyoshi, Nigel Unwin · Nature · 2003 · 1.3K citations
Acetylcholine receptor channel imaged in the open state
Nigel Unwin · Nature · 1995 · 1K citations